
News|Articles|July 1, 2015
Biologics Development and Manufacturing Trends, Part 1
Eric Langer, Managing partner at BioPlan Associates, speaks with Pharmaceutical Technology about the results from the 12th annual BioPlan Associates survey, and single use technology adoption.
Advertisement
Eric Langer, Managing Partner at BioPlan Associates, spoke with Pharmaceutical Technology about the results from the 12th annual BioPlan Associates survey, and single use technology adoption.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
2
Gene Therapy, Rare Diseases, and Transfer RNA
3
Medable Presents AI Agent for Automating Trial Master File Processes at JP Morgan Healthcare Conference
4
Amgen Acquires UK Biotech Dark Blue Therapeutics
5




